drugset
drugset / Trial / NCT00263796

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

NCT00263796 ↗

Phase 1 Completed 16 enrolled Anagnostou, Evdokia, M.D.
RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effect of oxytocin on face processing and response inhibition in autistic adults by fMRI.

Timeline

Start
2006-03
Primary completion
2010-10
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 10 iu Intravenous

Indications

autism